Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities
Objectives: To evaluate the in vivo effect of xanthine oxidase (XO) inhibition by allopurinol on the determination of polymorphic N-acetyltransferase 2 (NAT2) and cytochrome P450 1A2 (CYP1A2) with urinary caffeine metabolic ratios.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 1999
|
| In: |
European journal of clinical pharmacology
Year: 1999, Jahrgang: 54, Heft: 11, Pages: 869-876 |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s002280050569 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s002280050569
|
| Verfasserangaben: | P. Fuchs, W. E. Haefeli, H. R. Ledermann, M. Wenk |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1759031062 | ||
| 003 | DE-627 | ||
| 005 | 20220819215145.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210527s1999 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s002280050569 |2 doi | |
| 035 | |a (DE-627)1759031062 | ||
| 035 | |a (DE-599)KXP1759031062 | ||
| 035 | |a (OCoLC)1341413760 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fuchs, P. |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities |c P. Fuchs, W. E. Haefeli, H. R. Ledermann, M. Wenk |
| 264 | 1 | |c January 1999 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.05.2021 | ||
| 520 | |a Objectives: To evaluate the in vivo effect of xanthine oxidase (XO) inhibition by allopurinol on the determination of polymorphic N-acetyltransferase 2 (NAT2) and cytochrome P450 1A2 (CYP1A2) with urinary caffeine metabolic ratios. | ||
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 700 | 1 | |a Ledermann, H. R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wenk, Markus |d 1942- |e VerfasserIn |0 (DE-588)1124599215 |0 (DE-627)878826734 |0 (DE-576)163528268 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical pharmacology |d Berlin : Springer, 1968 |g 54(1999), 11, Seite 869-876 |h Online-Ressource |w (DE-627)253722829 |w (DE-600)1459058-X |w (DE-576)072372613 |x 1432-1041 |7 nnas |a Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities |
| 773 | 1 | 8 | |g volume:54 |g year:1999 |g number:11 |g pages:869-876 |g extent:8 |a Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s002280050569 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210527 | ||
| 993 | |a Article | ||
| 994 | |a 1999 | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1759031062 |e 3931732576 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities","title":"Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities"}],"relHost":[{"id":{"issn":["1432-1041"],"zdb":["1459058-X"],"eki":["253722829"]},"titleAlt":[{"title":"Clinical pharmacology"},{"title":"EJCP"},{"title":"Pharmacologia clinica"}],"note":["Gesehen am 11.10.05"],"part":{"text":"54(1999), 11, Seite 869-876","extent":"8","year":"1999","pages":"869-876","volume":"54","issue":"11"},"recId":"253722829","pubHistory":["1.1968/69 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"European journal of clinical pharmacology","title":"European journal of clinical pharmacology"}],"origin":[{"publisher":"Springer","dateIssuedDisp":"1968-","dateIssuedKey":"1968","publisherPlace":"Berlin ; Heidelberg ; New York"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["organ of European Association for Clinical Pharmacology and Therapeutics (EACPT)"]},"disp":"Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activitiesEuropean journal of clinical pharmacology","language":["eng"]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["P. Fuchs, W. E. Haefeli, H. R. Ledermann, M. Wenk"]},"id":{"doi":["10.1007/s002280050569"],"eki":["1759031062"]},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"January 1999"}],"language":["eng"],"person":[{"display":"Fuchs, P.","given":"P.","role":"aut","roleDisplay":"VerfasserIn","family":"Fuchs"},{"family":"Haefeli","given":"Walter E.","role":"aut","roleDisplay":"VerfasserIn","display":"Haefeli, Walter E."},{"given":"H. R.","roleDisplay":"VerfasserIn","role":"aut","display":"Ledermann, H. R.","family":"Ledermann"},{"family":"Wenk","display":"Wenk, Markus","given":"Markus","roleDisplay":"VerfasserIn","role":"aut"}],"recId":"1759031062","note":["Gesehen am 27.05.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a FUCHSPHAEFXANTHINEOX1999 | ||